Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria
NCT04264312 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76220
Last updated 2020-02-11
Summary
Through two-stage stratified cluster sampling, investigators studied the antiviral treatment rate and the main factors affecting the antiviral treatment in community chronic HBV infection-related liver disease population.
Conditions
Sponsors & Collaborators
-
Wu Jiang
lead OTHER_GOV
Principal Investigators
-
Jiang Wu · Beijing Center for Disease Prevention and Control
Eligibility
- Min Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-28
- Primary Completion
- 2019-09-28
- Completion
- 2020-01-10
Countries
- China
Study Locations
More Related Trials
-
Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy
NCT02412592 ·Status: UNKNOWN
-
Research on Clinical Recovery and Maintenance Strategies for CHB
NCT06803368 ·Status: RECRUITING ·Phase: NA
-
The Study on Optimal Treatment and Clinical Outcome of Chronic Hepatitis B Patients With Inactive Hypoviremia
NCT05357235 ·Status: UNKNOWN
-
Antiviral Therapy for Patients With Chronic Hepatitis B Infection
NCT05382351 ·Status: UNKNOWN ·Phase: PHASE2
-
Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)
NCT01155427 ·Status: COMPLETED
-
Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection
NCT01480492 ·Status: COMPLETED ·Phase: NA
-
Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B
NCT04028856 ·Status: COMPLETED
-
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
NCT03546530 ·Status: COMPLETED ·Phase: NA
-
Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years
NCT04565262 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
NCT06777173 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B
NCT01533051 ·Status: UNKNOWN
-
Treatment and Prognosis of Patients With Chronic HBV Infection
NCT05392387 ·Status: RECRUITING
-
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00324961 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
NCT05661786 ·Status: RECRUITING
-
Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
NCT02327663 ·Status: UNKNOWN ·Phase: PHASE4
-
Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B
NCT02532413 ·Status: UNKNOWN ·Phase: PHASE4
-
EFFicacy Optimization Research of Telbivudine Therapy
NCT00962533 ·Status: COMPLETED ·Phase: PHASE4
-
Entecavir for Chronic Hepatitis B
NCT01323452 ·Status: COMPLETED
-
Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy
NCT05792878 ·Status: UNKNOWN
-
Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection
NCT00810524 ·Status: UNKNOWN ·Phase: PHASE4
-
Real-world Study Optimizing Nucleotide-analogues
NCT05937178 ·Status: RECRUITING
-
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
NCT04189276 ·Status: UNKNOWN ·Phase: PHASE2
-
A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB
NCT01935635 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B
NCT03357822 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B
NCT02075294 ·Status: COMPLETED